Low-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Ki Hong Lee, Hyung Wook Park
Korean J Intern Med. 2023;38(5):583-594. Published online September 1, 2023
In the last decade, non-vitamin K antagonist oral anticoagulants (NOACs), a new generation of OACs, were introduced to prevent thromboembolism in patients with atrial fibrillation. Although vitamin K-dependent anticoagulants have long been used as OACs, their inherent disadvantage of considerable bl..
|